CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
For the period ended Dec 31, 2024. Filed Mar 14, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 14, 2025
CELZ$0.61-1.6%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Table of Contents
| Item · Description · Page | |||
|---|---|---|---|
| Part I | |||
| 1. | Business | 4 | |
| 1A. | Risk Factors | 22 | |
| 1B. | Unresolved Staff Comments | 21 | |
| 1C | Cybersecurity | 32 | |
| 2. | Properties | 32 | |
| 3. | Legal Proceedings | 32 | |
| 4. | Mine Safety Disclosures | 32 | |
| Part II | |||
| 5. | Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities | 33 | |
| 6. | Selected Financial Data | 35 | |
| 7. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 36 | |
| 7A. | Quantitative and Qualitative Disclosures About Market Risk | 41 | |
| 8. | Financial Statements and Supplementary Data | F-1 | |
| 9. | Changes in and Disagreements with Accountants on Accounting and Financial Disclosure | 42 | |
| 9A. | Controls and Procedures | 42 | |
| 9B. | Other Information | 42 | |
| Part III | |||
| 10. | Directors, Executive Officers and Corporate Governance | 43 | |
| 11. | Executive Compensation | 43 | |
| 12. | Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters | 43 | |
| 13. | Certain Relationships and Related Transactions and Director Independence | 43 | |
| 14. | Principal Accountant Fees and Services | 43 | |
| Part IV | |||
| 15. | Exhibits, Financial Statement Schedules | 44 | |
| Signatures | 46 | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.